JP2013541333A5 - - Google Patents

Download PDF

Info

Publication number
JP2013541333A5
JP2013541333A5 JP2013529096A JP2013529096A JP2013541333A5 JP 2013541333 A5 JP2013541333 A5 JP 2013541333A5 JP 2013529096 A JP2013529096 A JP 2013529096A JP 2013529096 A JP2013529096 A JP 2013529096A JP 2013541333 A5 JP2013541333 A5 JP 2013541333A5
Authority
JP
Japan
Prior art keywords
seq
bacteriophage
protein
fragment
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013529096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541333A (ja
JP6058540B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/PT2011/000031 external-priority patent/WO2012036580A2/en
Publication of JP2013541333A publication Critical patent/JP2013541333A/ja
Publication of JP2013541333A5 publication Critical patent/JP2013541333A5/ja
Application granted granted Critical
Publication of JP6058540B2 publication Critical patent/JP6058540B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013529096A 2010-09-17 2011-09-19 抗菌性ファージ、ファージペプチド、及びそれらの使用方法 Active JP6058540B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38401510P 2010-09-17 2010-09-17
US61/384,015 2010-09-17
PCT/PT2011/000031 WO2012036580A2 (en) 2010-09-17 2011-09-19 Antibacterial phage, phage peptides and methods of use thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2015243657A Division JP6234983B2 (ja) 2010-09-17 2015-12-14 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2016181177A Division JP6355691B2 (ja) 2010-09-17 2016-09-16 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2013541333A JP2013541333A (ja) 2013-11-14
JP2013541333A5 true JP2013541333A5 (enExample) 2015-04-16
JP6058540B2 JP6058540B2 (ja) 2017-01-11

Family

ID=45755483

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013529096A Active JP6058540B2 (ja) 2010-09-17 2011-09-19 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2015243657A Active JP6234983B2 (ja) 2010-09-17 2015-12-14 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2016181177A Active JP6355691B2 (ja) 2010-09-17 2016-09-16 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015243657A Active JP6234983B2 (ja) 2010-09-17 2015-12-14 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2016181177A Active JP6355691B2 (ja) 2010-09-17 2016-09-16 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Country Status (13)

Country Link
US (3) US9222077B2 (enExample)
EP (4) EP3789031B1 (enExample)
JP (3) JP6058540B2 (enExample)
CN (1) CN103732235B (enExample)
AU (3) AU2011302722B2 (enExample)
BR (1) BR112013006400B1 (enExample)
CA (3) CA3154006C (enExample)
ES (3) ES2703629T3 (enExample)
PL (1) PL3789031T3 (enExample)
PT (2) PT2616087T (enExample)
RU (2) RU2725726C2 (enExample)
SG (1) SG188566A1 (enExample)
WO (1) WO2012036580A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2703629T3 (es) * 2010-09-17 2019-03-11 Tecnifar Ind Tecnica Farmaceutica S A Fago antibacteriano, péptidos de fago y métodos de uso de los mismos
DK2833899T3 (da) * 2012-03-19 2020-09-28 Tecnifar Ind Tecnica Farmaceutica S A Sammensætninger, der omfatter cocktails af antibakterielle fager, og anvendelser deraf til behandling af bakterieinfektioner
NZ701651A (en) 2012-05-07 2016-09-30 Micreos B V A bacteriophage for biocontrol of salmonella and in the manufacturing or processing of foods
EP2799063A1 (en) * 2013-04-30 2014-11-05 Ferring B.V. Bacteriophage therapy
EP2865383A1 (en) * 2013-10-25 2015-04-29 Pherecydes Pharma Phage therapy of pseudomonas infections
EP2893933A1 (en) * 2014-01-10 2015-07-15 Pherecydes Pharma Phage Therapy of E coli infections
CN103981154B (zh) * 2014-05-28 2016-07-06 大连理工大学 一种铜绿假单胞菌噬菌体及其在水貂出血性肺炎预防中的应用
CN106659748B (zh) * 2014-06-26 2021-08-31 洛克菲勒大学 不动杆菌属溶素
EP3018201A1 (en) * 2014-11-07 2016-05-11 Pherecydes Pharma Phage therapy
CA3254091A1 (en) * 2014-12-16 2025-10-27 C3J Therapeutics, Inc. Compositions of and methods for in vitro viral genome engineering
EP4151228A3 (en) * 2015-09-17 2023-06-14 Contrafect Corporation Lysin polypeptides active against gram-negative bacteria
CA3012069C (en) * 2016-03-28 2021-11-16 Illumina, Inc. Recombinase mutants
JP7154543B2 (ja) * 2016-12-05 2022-10-18 テクノファージ インヴェスティガサォン エ デセンヴォルヴィメント エム ビオテクノロジア エスィアー 呼吸器抗菌性ファージを含むバクテリオファージ組成物、およびその使用法
EP3584315A4 (en) * 2017-02-17 2020-09-16 Intron Biotechnology, Inc. NEW BACTERIOPHAGE PSE-AEP-4 OF PSEUDOMONAS AERUGINOSA AND ITS USE IN INHIBITION OF THE PROLIFERATION OF PSEUDOMONAS AERUGINOSA
GB201712145D0 (en) * 2017-07-28 2017-09-13 Univ Leuven Kath Novel dnase
EP3802814A1 (en) 2018-05-30 2021-04-14 Lysando AG Novel antimicrobial proteins
WO2020130652A2 (ko) * 2018-12-18 2020-06-25 연세대학교 산학협력단 세균을 용균하는 신규한 박테리오파지
US20220073567A1 (en) * 2018-12-24 2022-03-10 Mikroliz Biyoteknoloji San. Ve Tic. Ltd. Sti. Acinetobacter baumannii bacteriophage mikab48 or lytic protein derived from the bacteriophage
US12396460B2 (en) * 2019-06-17 2025-08-26 Precisio Biotix Therapeutics, Inc. Bacterial control through dispersion of bacteriophage powders
RU2717972C1 (ru) * 2019-06-28 2020-03-27 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 324 (500318), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717435C1 (ru) * 2019-06-28 2020-03-23 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 326 (500320), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717022C1 (ru) * 2019-06-28 2020-03-17 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 328 (500322), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717026C1 (ru) * 2019-06-28 2020-03-17 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 325 (500319), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717420C1 (ru) * 2019-06-28 2020-03-23 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 327 (500321), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717451C1 (ru) * 2019-06-28 2020-03-23 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 323 (500317), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717973C1 (ru) * 2019-06-28 2020-03-27 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 322 (500316), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2707505C1 (ru) * 2019-09-17 2019-11-27 федеральное государственное бюджетное образовательное учреждение высшего образования "Приволжский исследовательский медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО "ПИМУ" Минздрава России) Способ лечения бактериальных инфекций дыхательных путей
US20210187046A1 (en) 2019-12-19 2021-06-24 Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa Cocktail compositions comprising respiratory antibacterial phages and methods of use thereof
CN113214364B (zh) * 2020-01-21 2022-11-22 天津大学 一种多重耐药鲍曼不动杆菌识别元件的挖掘与验证
FR3110574A1 (fr) * 2020-05-20 2021-11-26 Vetophage Capture de bacteries a l’aide de bacteriophages ou de proteines de bacteriophage
WO2021235876A1 (ko) 2020-05-22 2021-11-25 주식회사 라이센텍 신규한 폴리펩타이드, 융합 폴리펩타이드, 및 이를 포함하는 그람음성균에 대한 항생제
EP4199961A4 (en) * 2020-08-20 2024-03-13 The Board of Regents of the University of Texas System Combination immunotherapy methods for the treatment of cancer
US20240415904A1 (en) * 2021-05-12 2024-12-19 Biomx Ltd. Staphylococcus bacteriophage and uses thereof
WO2023101639A1 (en) * 2021-11-30 2023-06-08 Yildiz Teknik Universitesi Antimicrobial agent for lysis of s. aureus
CN114807106B (zh) * 2022-04-25 2023-09-01 昆明市延安医院 一种裂解酶pEf51和穿孔素蛋白pEf191的应用
WO2024182314A2 (en) * 2023-02-27 2024-09-06 The Regents Of The University Of California Proteins that inhibit cyclic-oligonucleotide-based anti-phage signaling system (cbass)
US20250160335A1 (en) * 2023-11-16 2025-05-22 The United States Of America, As Represented By The Secretary Of Agriculture Formulation of a lytic bacteriophage cocktail for biocontrol of shiga toxin-producing escherichia coli strains
CN119139561A (zh) * 2024-11-15 2024-12-17 浙江大学 一种噬菌体复合水凝胶及其制备方法和在促进牙槽骨修复中的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
EP0575908B1 (de) * 1992-06-25 2000-03-15 Aventis Research & Technologies GmbH & Co. KG Pseudomonas aeruginosa und seine Verwendung zur Herstellung von L-Rhamnose
EP0755441A4 (en) 1994-04-05 2000-01-26 Exponential Biotherapies Inc Antibacterial therapy with genotypically modified bacteriophage
RU2112800C1 (ru) * 1996-03-29 1998-06-10 Государственный научный центр прикладной микробиологии Штамм пилеспецифического бактериофага pseudomonas aeruginosa гнцпм n 03, используемый для приготовления лечебного препарата против синегнойной палочки
CA2251724A1 (en) 1996-04-15 1997-10-23 Paul Averback Compositions containing bacteriophages and methods of using bacteriophages to treat infections
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US7138419B2 (en) * 2000-12-27 2006-11-21 Corus Pharma, Inc. Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
DE10115310A1 (de) 2001-03-28 2002-10-10 Nodar A Daniela Bakteriophagen-Präparation
DE60315636T2 (de) 2002-03-25 2008-05-08 University Of Warwick, Coventry Zur therapie und prophylaxe bakterieller infektionen geeignete bakteriophagen
GB0300597D0 (en) * 2003-01-10 2003-02-12 Microbiological Res Authority Phage biofilms
US20050095222A1 (en) 2003-10-29 2005-05-05 Taro Suzuki Allergen inhibitor, allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet
EP1833497A4 (en) 2004-11-02 2009-11-11 Cangagen Life Sciences Inc BACTERIOPHAGE COMPOSITIONS
WO2006047870A1 (en) 2004-11-02 2006-05-11 Gangagen Life Sciences Inc. Stabilized bacteriophage formulations
CA2593992A1 (en) 2004-12-06 2006-06-15 Rodney M. Donlan Inhibition of biofilm formation using bacteriophage
CA2609357A1 (en) 2005-05-26 2006-11-30 Gangagen Life Sciences Inc. Bacterial management in animal holding systems
MX2008014150A (es) * 2006-05-05 2009-02-04 Gangagen Inc Actividades antimicrobianas derivadas de fago.
IE20060488A1 (en) * 2006-06-29 2008-01-09 Teagasc Agric Food Dev Authori Recombinant staphylococcal phage lysin as an antibacterial agent
CN101003793A (zh) * 2007-01-11 2007-07-25 中国人民解放军第三军医大学 噬菌体对环境中致病菌的净化技术
US20110143997A1 (en) 2007-03-30 2011-06-16 Dow Agrosciences Llc Phage receptor binding proteins for antibacterial therapy and other novel uses
EP2103308A1 (de) * 2008-03-20 2009-09-23 PhytoLine GmbH Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen
CA2638130A1 (en) * 2008-07-21 2010-01-21 Canadian Forest Products Ltd. Composite wood product and method of manufacture utilizing wood infected by bark beetles
AU2009273845B2 (en) * 2008-07-24 2016-02-04 The United State Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
GB0815484D0 (en) * 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
EP2571984A2 (en) * 2008-10-10 2013-03-27 Lusomedicamenta, S.A. Antibacterial phage peptides and methods of use thereof
KR101016918B1 (ko) * 2009-01-08 2011-02-25 주식회사 인트론바이오테크놀로지 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질
ES2761835T3 (es) 2009-02-06 2020-05-21 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Fagos antibacterianos, péptidos de fagos y métodos de uso de los mismos
BRPI1015203B1 (pt) 2009-06-26 2021-06-01 Lysando Ag Proteína de fusão composta por uma endolisina e uma extensão de peptídeo anfifática, usos da mesma e composição farmacêutica que compreende a dita proteína
ES2703629T3 (es) * 2010-09-17 2019-03-11 Tecnifar Ind Tecnica Farmaceutica S A Fago antibacteriano, péptidos de fago y métodos de uso de los mismos
EP2697387B1 (en) * 2011-04-12 2021-09-15 Bactoclear Holdings PTE. LTD. Chimeric antibacterial polypeptides

Similar Documents

Publication Publication Date Title
JP2013541333A5 (enExample)
RU2013117275A (ru) Бактериофаги, фаговые пептиды и способы их применения
JP2012517225A5 (enExample)
Nguyen et al. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review
Weber-Dabrowska et al. Bacteriophage therapy for infections in cancer patients
Bhargava et al. Phage therapeutics: from promises to practices and prospectives
RU2011134315A (ru) Бактериофаги, белки бактериофагов и способы их применения
JP6769871B2 (ja) E.coli感染のファージを用いての治療
CN106659748B (zh) 不动杆菌属溶素
BR112017009545B1 (pt) Composição antibacteriana farmacêutica ou veterinária e método in vitro para a preparação de uma composição farmacêutica ou veterinária
JP7492337B2 (ja) ファージ療法
BR112016009062B1 (pt) Composição antibacteriana, método para a preparação de uma composição, método in vitro para prever ou determinar a eficácia de uma terapia de bacteriófago em um indivíduo e método in vitro para selecionar um indivíduo ou determinar se um indivíduo é susceptível de se beneficiar de uma terapia com bacteriófagos
Kamel et al. Characterization of bee venom and its synergistic effect combating antibiotic resistance of Pseudomonas aeruginosa
CN107177580B (zh) 一种广谱新型嵌合裂解酶GBS-PlySb及其编码基因和应用
Lindford et al. Successful eradication of multidrug resistant Acinetobacter in the Helsinki Burn Centre
MORRISETTE et al. Bacteriophage-antibiotic combinations: A promising alternative for refractory infections?
US20240409910A1 (en) Recombinant polypeptide for use as a medicine, antiseptic agent, antibacterial agent, anti-inflammatory agent, compositions comprising it and uses thereof
Lee et al. Enterococcus Phage vB_EfaS_HEf13 as an Anti-biofilm Agent against Enterococcus faecalis
Bilska-Stokłosa et al. Streptococcus constellatus as an aetiological factor of extensive neck phlegmon complicated by sepsis–case study
Wang et al. A novel chimeric endolysin Cly2v shows potential in treating streptococci-induced bovine mastitis and systemic infections
WO2016146037A1 (zh) 用于抑制/瓦解生物被膜的抑制剂及其应用
Orole et al. Distribution of resistance genes and resistance profile of methicillin-resistant Staphylococcus aureus among animal handlers in Animal Market, Jos
Su et al. Cutaneous type of nocardiosis caused by Nocardia brasiliensis in an elderly patient
Hameed A comparative study of antibacterial activity between honey and antibiotics against some pathogenic bacteria.
Ma et al. vB_PaeP_PZH3, a novel bacteriophage for the treatment of MDR Pseudomonas aeruginosa in a mouse wound infection model